Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 697 across all filing types
Latest filing 2024-05-06 Investor Presentation
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
News release - French.pdf
Investor Presentation Classification · 95% confidence The document is a press release dated 06/05/2024 from Diagnos inc. announcing their participation and presentations at the ARVO 2024 annual meeting. It describes the topics of their presentations related to AI solutions for retinal health, including technical details about their models and research focus. There is no financial data, no regulatory filing, no voting results, no management changes, no earnings or annual report content. The document is a corporate announcement about upcoming presentations at a scientific conference, not a financial or regulatory report. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best as an Investor Presentation (IP) type, as it is a detailed presentation of company technology and strategy aimed at investors and stakeholders, highlighting innovation and market positioning. Confidence is high given the clear nature of the document as a presentation announcement and description.
2024-05-06 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated April 16, 2024, from Diagnos Inc. announcing plans to accelerate medical device license applications to Health Canada and the US FDA for new AI analysis modules, and plans to obtain ISO 27001 certification. It discusses product development, regulatory approval efforts, and business outlook but does not contain financial statements, earnings data, or detailed financial analysis. It is a corporate announcement about product and regulatory progress rather than a financial report or regulatory filing. The document length is 4313 characters, which is relatively short and typical for a press release. There is no indication that this is an Annual Report, Interim Report, Earnings Release, or any other detailed financial or regulatory filing. It is not a report publication announcement since it does not mention an attached report or provide a link to a report. The content fits best with a general Regulatory Filing (RNS) as it is a regulatory announcement about product licensing and certification plans without financial data or voting results or management changes.
2024-04-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Diagnos Inc. is expediting applications for medical device licenses with Health Canada and the US FDA for new AI analysis modules, and planning ISO 27001 certification. It discusses future plans, regulatory approvals, and business growth opportunities. There are no financial statements, earnings data, or detailed financial analysis present. The document is an update on regulatory and business developments rather than a formal financial report or filing. It is also relatively short (3813 characters) and reads like a news announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2024-04-16 English
News release - English.pdf
Regulatory Filings
2024-04-09 English
News release - English.pdf
Director's Dealing Classification · 100% confidence The document is a press release announcing the grant of stock options to a company director. It details the number of options, vesting schedule, exercise price, and expiration date. There is no financial report, earnings data, or regulatory filing content. The announcement relates to a director's personal share-related transaction (stock options grant). This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is short and focused solely on this announcement, confirming it is not a full report or other filing type.
2024-04-03 English
News release - French.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the granting of stock options to a company director. It details the number of options, vesting schedule, exercise price, and expiration date. There is no financial report, earnings data, or detailed financial statements included. The document is short (2656 characters) and serves as a corporate announcement regarding a capital-related transaction (stock options granted). This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock option grants.
2024-04-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.